VersaPharm

Marietta, United States Founded: 1995 • Age: 31 yrs Acquired By Akorn
Generic pharmaceuticals are developed and marketed in key categories.
Request Access

About VersaPharm

VersaPharm is a company based in Marietta (United States) founded in 1995 was acquired by Akorn in May 2014.. VersaPharm has completed 1 acquisition, including Xanodyne Pharmaceuticals.

  • Headquarter Marietta, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
  • Acquired by
    Akorn

    (May 09, 2014)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of VersaPharm

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in VersaPharm

VersaPharm has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Akorn. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Injectable and ophthalmic pharmaceutical products were manufactured across therapeutic areas.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by VersaPharm

VersaPharm has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Xanodyne Pharmaceuticals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Developer of drugs for women's health and pain management
2001
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - VersaPharm

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Versapharm Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of VersaPharm

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Versapharm

Frequently Asked Questions about VersaPharm

When was VersaPharm founded?

VersaPharm was founded in 1995.

Where is VersaPharm located?

VersaPharm is headquartered in Marietta, United States. It is registered at Marietta, Georgia, United States.

What does VersaPharm do?

VersaPharm was founded in 1995 in Marietta, United States, focusing on the generic pharmaceuticals sector. Operations centered on developing and marketing products across categories including dermatology, tuberculosis, and hemophilia. FDA approval was secured for generic injectable rifampin. The company was acquired by Tailwind Capital in 2007 and later sold to Akron, reflecting shifts in ownership within the industry.

How many acquisitions has VersaPharm made?

VersaPharm has made 1 acquisition, including Xanodyne Pharmaceuticals.

Who are VersaPharm's investors?

VersaPharm has 1 investor. Key investors include Akorn.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available